GO
Loading...

Acquisitions

More

  • SAO PAULO, July 2- Mergers and acquisitions in Brazil are expected to gain steam by the year-end as economic and political risks ease, helping companies and private-equity firms scouring for takeover targets focus on tapping the country's long-term potential.

  • BRUSSELS, July 2- Spain's Telefonica won EU antitrust clearance for its 8.6- billion-euro takeover of KPN's German mobile arm, giving it a stronger position in Europe's largest phone market and marking a milestone in telecoms consolidation.

  • BOSTON, July 1- Activist investor William Ackman has hired Credit Suisse in his fight to have Valeant Pharmaceuticals acquire Botox maker Allergan Inc., a person familiar with the matter said on Tuesday.

  • Google buys music streaming service Songza Tuesday, 1 Jul 2014 | 4:00 PM ET

    SAN FRANCISCO, July 1- Google Inc has acquired streaming music service Songza, the Internet search company's latest move to play a bigger role in the fast-growing online music business. Google said on Tuesday it would explore ways to incorporate aspects of Songza into its existing streaming music service over the coming months.

  • NEW YORK and LOS ANGELES, July 1- Allergan Inc may take on debt to buy back its own shares as part of a multi-faceted plan to thwart a $53 billion takeover bid by Valeant Pharmaceuticals International Inc and activist investor William Ackman.

  • NEW YORK and LOS ANGELES, July 1- Allergan Inc may take on debt to buy back its own shares as part of a multi-faceted plan to thwart a $53 billion takeover bid by Valeant Pharmaceuticals International Inc and activist investor William Ackman.

  • Under Chief Executive Frans van Houten, the Dutch company- which started out 120 years ago as a pioneer in electric lighting- has been shifting away from the consumer electronics sector in a restructuring which has involved more than 5,000 job cuts and the sale of its television business.

  • June 26- Private-label food retailer TreeHouse Foods Inc is in late-stage talks to acquire Flagstone Foods, a maker of dried fruits and nuts, for between $800 million and $900 million, people familiar with the matter said on Thursday.

  • *Combined company will have about $1.4 bln annual sales. FRANKFURT, June 26- Austria's AMS is in talks to buy German peer Dialog Semiconductor to create a European chipmaker with a market value of about $4.7 billion that could better tap the growing market for web-connected devices.

  • June 26- Auxilium Pharmaceuticals Inc would buy Canadian drugmaker QLT Inc in a deal valued at about $850 million to add QLT's experimental treatment for eye diseases caused by gene mutations. Auxilium shares were up 18 percent at $25 in premarket trade, while QLT's U.S.-listed shares rose 30 percent to $7.

  • Auxilium Pharma to buy Canadian eye drug maker QLT Thursday, 26 Jun 2014 | 7:30 AM ET

    June 26- Auxilium Pharmaceuticals Inc said it would buy Canadian eye drug maker QLT Inc in an all-stock deal to gain access to QLT's experimental treatment for retinal diseases caused by gene mutations.

  • Cancer drug setback tarnishes AstraZeneca's R&D claims Thursday, 26 Jun 2014 | 6:31 AM ET

    *AstraZeneca mis-steps may revive prospects of takeover. LONDON, June 26- A vote by U.S. experts against accelerated approval of a new ovarian cancer drug from AstraZeneca has dented its claims of research prowess, which were used to see off a $118 billion bid from Pfizer.

  • LONDON, June 26- The London Stock Exchange Group said it planned to acquire U.S.-based asset manager and stock exchange provider Frank Russell for $2.7 billion, with the help of a $1.6 billion rights issue, as it ramps up its U.S. presence.

  • *Says deal would boost new AbbVie's adjusted EPS materially. LONDON, June 25- U.S. drugmaker AbbVie said on Wednesday it wanted to move rapidly to clinch a takeover of Shire as it set out the strategic rationale for buying the London- listed company, which has spurned its $46 billion offer.

  • LONDON, June 25- U.S. drugmaker AbbVie set out the strategic rationale for acquiring Shire on Wednesday as a battle for control of the London- listed company, which has spurned AbbVie's $46 billion bid, entered a new phase.

  • *Move bolsters Shire in defence against AbbVie. *AbbVie to put its case to Shire shareholders- source. LONDON, June 25- Shire, which has spurned a $46 billion takeover offer from U.S. group AbbVie as inadequate, has a new reason to argue it is worth more after a U.S. court backed patent claims on its top-selling drug Vyvanse.

  • *Syngenta declines to comment on report of Monsanto talks. ZURICH, June 24- Syngenta's shares jumped on Tuesday after a media report that the Swiss crop chemical maker had been in talks about a $40 billion takeover by U.S. rival Monsanto Co to create the world's largest agrochemical company.

  • TORONTO, June 24- Two large groups of investors that control roughly 20 percent of the shares of Tuckamore Capital Management Inc have gone public with their discontent over a management-led buyout of the firm, being sponsored by Birch Hill, a private equity player.

  • LONDON/ MADRID, June 24- Private equity firm KKR is to buy a one-third stake in indebted Spanish group Acciona's international wind farms arm for 417 million euros, the companies said on Tuesday, with a view to listing the business next year.

  • Death of the desktop?     Tuesday, 24 Jun 2014 | 8:37 AM ET

    Scott McNealy, Sun Microsystems co-founder, shares his thoughts on the future of the PC and the "Internet of things."